Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Eidos Therapeutics Inc. (EIDX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
EIDX Insider Trading Transactions for Eidos Therapeutics  Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-12-10
Purchase(A)
2018-12-13
6:14 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
40,653 $13.33 $542,063 22,589,300
(Direct)
View
2018-12-06
Purchase(A)
2018-12-13
6:13 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
80,144 $13.67 $1,095,867 22,548,648
(Direct)
View
2018-12-10
Sale
2018-12-12
5:44 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
40,653 $13.33 $542,063 22,589,300
(Direct)
View
2018-12-06
Sale
2018-12-10
7:25 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
80,144 $13.67 $1,095,867 22,548,648
(Direct)
View
2018-12-03
Purchase
2018-12-06
8:48 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
2,853,848 $14.92 $42,589,911 22,468,504
(Direct)
View
2018-06-22
Purchase
2018-06-26
4:30 pm
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
1,000,000 $17 $17,000,000 19,614,656
(Direct)
View
2018-06-22
Purchase
2018-06-22
7:33 pm
Eidos Therapeutics Inc. EIDX RA CAPITAL MANAGEMENT LLC
RA Capital Healthcare Fund LP
Kolchinsky Peter
Director
1,058,824 $17 $18,000,008 2,162,671
(Indirect)
View
2018-06-22
Purchase
2018-06-22
7:00 pm
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
1,058,824 $17 $18,000,008 2,162,671
(Indirect)
View
2018-06-22
Purchase
2018-06-22
6:56 pm
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
1,000,000 $17 $17,000,000 19,614,656
(Indirect)
View
2018-06-22
Purchase
2018-06-22
6:56 pm
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
1,000,000 $17 $17,000,000 19,614,656
(Indirect)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-12-04
Option Award
2018-12-07
8:42 pm
N/A
2028-12-04
Eidos Therapeutics Inc. EIDX Lis William
Director
43,056 $13.67 43,056
(Direct)
View
2018-11-05
Option Award
2018-11-07
7:11 pm
N/A
2028-11-05
Eidos Therapeutics Inc. EIDX Siu Christine
See Remarks
55,000 $13.2 55,000
(Direct)
View
2018-11-05
Option Award
2018-11-07
7:08 pm
N/A
2028-11-05
Eidos Therapeutics Inc. EIDX Fox Jonathan C
See Remarks
70,000 $13.2 70,000
(Direct)
View
2018-11-05
Option Award
2018-11-07
7:06 pm
N/A
2028-11-05
Eidos Therapeutics Inc. EIDX Sinha Uma
Chief Scientific Officer
60,000 $13.2 60,000
(Direct)
View
2018-07-01
Option Award
2018-07-03
7:05 pm
N/A
2028-06-30
Eidos Therapeutics Inc. EIDX AGUIAR ERIC
Director
43,056 $20.34 43,056
(Direct)
View
2018-07-01
Option Award
2018-07-03
7:03 pm
N/A
2028-06-30
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
43,056 $20.34 43,056
(Direct)
View
2018-07-01
Option Award
2018-07-03
7:02 pm
N/A
2028-06-30
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
43,056 $20.34 43,056
(Direct)
View
2018-06-22
Conversion
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
18,826,416 $0 19,614,656
(Direct)
View
2018-06-22
Tax Withholding
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
211,762 $17 19,614,656
(Direct)
View
2018-06-22
Exercise
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
332,262 $10.83 19,614,656
(Direct)
View
2018-06-22
Exercise
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
332,262 $0 19,614,656
(Direct)
View
2018-06-22
Conversion
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
2,909,029 $0 19,614,656
(Direct)
View
2018-06-22
Conversion
2018-06-26
4:30 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX BridgeBio Pharma LLC
10% Owner
12,832,123 $0 19,614,656
(Direct)
View
2018-06-22
Conversion
2018-06-22
7:33 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX RA CAPITAL MANAGEMENT LLC
RA Capital Healthcare Fund LP
Kolchinsky Peter
Director
1,103,847 $0 2,162,671
(Indirect)
View
2018-06-22
Conversion
2018-06-22
7:33 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX RA CAPITAL MANAGEMENT LLC
RA Capital Healthcare Fund LP
Kolchinsky Peter
Director
922,950 $0 2,162,671
(Indirect)
View
2018-06-22
Conversion
2018-06-22
7:00 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
1,103,847 $0 2,162,671
(Indirect)
View
2018-06-22
Conversion
2018-06-22
7:00 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
922,950 $0 2,162,671
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
18,826,416 $0 19,614,656
(Indirect)
View
2018-06-22
Tax Withholding
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
211,762 $17 19,614,656
(Indirect)
View
2018-06-22
Exercise
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
332,262 $10.83 19,614,656
(Indirect)
View
2018-06-22
Exercise
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
332,262 $0 19,614,656
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
2,909,029 $0 19,614,656
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Kumar Neil
CEO, 10% Owner
12,832,123 $0 19,614,656
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
18,826,416 $0 19,614,656
(Indirect)
View
2018-06-22
Tax Withholding
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
211,762 $17 19,614,656
(Indirect)
View
2018-06-22
Exercise
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
332,262 $10.83 19,614,656
(Indirect)
View
2018-06-22
Exercise
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
332,262 $0 19,614,656
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
2,909,029 $0 19,614,656
(Indirect)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director, 10% Owner
12,832,123 $0 19,614,656
(Indirect)
View
2018-06-22
Option Award
2018-06-22
6:55 pm
N/A
2028-06-21
Eidos Therapeutics Inc. EIDX Huh Hoyoung
Director
83,720 $17 83,750
(Direct)
View